MLS Capital Fund II logo

MLS Capital Fund II

Asia, Kuala Lumpur, Malaysia, Kuala Lumpur

Description

MLS Capital Fund II invests in a diversified portfolio of biogreentech companies at all stages of development.

Investor Profile

MLS Capital Fund II has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series D (50%)
  • Post Ipo Equity (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Agriculture
  • Agtech
  • Biotechnology
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does MLS Capital Fund II frequently co-invest with?

Fall Line Capital
North America, California, United States, San Mateo
Co-Investments: 2
Baird Capital
North America, Wisconsin, United States, Milwaukee
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 2
Jeremy and Hannelore Grantham Environmental Trust
North America, Massachusetts, United States, Boston
Co-Investments: 2
AgFunder
North America, California, United States, San Francisco
Co-Investments: 1
Lupa Systems
North America, New York, United States, New York
Co-Investments: 1
S2G Ventures
North America, Illinois, United States, Chicago
Co-Investments: 2
Lewis & Clark Ventures
North America, Missouri, United States, St Louis
Co-Investments: 1
Spruce Capital Partners
North America, California, United States, San Francisco
Co-Investments: 2
Continental Grain Company
North America, New York, United States, New York
Co-Investments: 2

What are some of recent deals done by MLS Capital Fund II?

Greenlight Biosciences

Medford, Massachusetts, United States

GreenLight Biosciences is a biotechnology company that develops an RNA platform for agriculture and human health.

AgricultureAgTechBiotechnologyLife Science
Post Ipo EquityFeb 3, 2022
Amount Raised: $125,500,000
Greenlight Biosciences

Medford, Massachusetts, United States

GreenLight Biosciences is a biotechnology company that develops an RNA platform for agriculture and human health.

AgricultureAgTechBiotechnologyLife Science
Series DJun 16, 2020
Amount Raised: $102,000,000